Carson Wealth (CWM LLC)
ACAD icon

Carson Wealth (CWM LLC)’s Acadia Pharmaceuticals ACAD Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$645K Sell
28,969
-4,818
-14% -$115K ﹤0.01% 1836
2025
Q4 		$902K Sell
33,787
-3,436
-9% -$82.1K ﹤0.01% 1555
2025
Q3 		$794K Buy
37,223
+9,901
+36% +$234K ﹤0.01% 1532
2025
Q2 		$589K Buy
27,322
+21,477
+367% +$399K ﹤0.01% 1516
2025
Q1 		$97K Buy
5,845
+1,951
+50% +$35.4K ﹤0.01% 2444
2024
Q4 		$71K Buy
3,894
+1,646
+73% +$26.6K ﹤0.01% 2515
2024
Q3 		$35K Buy
2,248
+136
+6% +$2.27K ﹤0.01% 2960
2024
Q2 		$34K Buy
2,112
+96
+5% +$1.55K ﹤0.01% 2738
2024
Q1 		$37K Buy
2,016
+24
+1% +$595 ﹤0.01% 2491
2023
Q4 		$62K Sell
1,992
-71
-3% -$1.7K ﹤0.01% 2036
2023
Q3 		$43K Sell
2,063
-144
-7% -$3.91K ﹤0.01% 2153
2023
Q2 		$53K Sell
2,207
-158
-7% -$3.51K ﹤0.01% 1931
2023
Q1 		$45K Buy
2,365
+2,335
+7,783% +$44.5K ﹤0.01% 1929
2022
Q4 		$0 Sell
30
-62
-67% -$969 ﹤0.01% 3936
2022
Q3 		$2K Sell
92
-6
-6% -$97 ﹤0.01% 3401
2022
Q2 		$1K Buy
98
+23
+31% +$429 ﹤0.01% 3468
2022
Q1 		$2K Buy
75
+43
+134% +$1.04K ﹤0.01% 3119
2021
Q4 		$1K Buy
+32
New +$644 ﹤0.01% 3235

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ACAD Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Acadia Pharmaceuticals (ACAD) stake by 14% in Q1 2026, selling an estimated $115K and leaving 28,969 shares worth $645K. The position accounts for ﹤0.01% of the portfolio, ranked #1836.

Carson Wealth (CWM LLC) first reported a position in ACAD in Q4 2021 and has held it in 18 quarters since. The position peaked at $902K in Q4 2025. 342 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • Carson Wealth (CWM LLC) held 28,969 shares of Acadia Pharmaceuticals worth $645K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 4,818 Acadia Pharmaceuticals shares in Q1 2026, an estimated $115K.
  • Acadia Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1836 holding.
  • Carson Wealth (CWM LLC) first reported a position in Acadia Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Carson Wealth (CWM LLC)'s Acadia Pharmaceuticals position peaked at $902K in Q4 2025.
  • 342 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.